ACTUAL CASE STUDIES: This information was presented by individuals who volunteered to use APeX, which was supplied free of charge, and elected to send redacted excerpts from their oncologist's medical report. This information was sent to APeX Institute without request or compensation. We have a library of similar APeX volunteer stories in our data base.)
Jim M. - Portland, Oregon, Stage IV Lung Cancer
Jim had been subjected to intense radiation and chemo and was finally faced with “getting his affairs in order.”
April 30, 2007; My cancer has been diagnosed as Stage 4 Lung cancer for which I have undergone 6 weeks of chemo therapy and a concurrent radiology series.
May 12, 2007; Begin APeX
June 21, 2007; Net results, in the lymph nodes between the lungs, the cancer has shrunk about half.
June 29, 2007; Had a CAT scan. The results are encouraging. The lymph nodes have shrunk some more. They are now less than half of what they were before APeX treatment. The right lung has no new growth and the cancer that was there is now just black spots and very small. My doctor says my blood work is absolutely perfect. Red and white count is spot on. And the other things they watch are right where they should be.
July 15, 2007; I saw my Oncologist Friday; she’s very pleased about the progress. Still some scar tissue but that’s getting smaller. I
Sept. 28, 2007; My last CT Scan showed NO sign of cancer. I asked my Dr. what stage the lung cancer was or is in, after all this treatment and so on. She told me it was gone, so I asked, “Is it in remission?” She said, “No, it’s gone. As in, not there anymore. She mentioned that she is confused, that this is very rare for lung cancer, especially my type.
Paul S., Atlanta, Georgia - Stage IV Prostate Cancer
Paul S. was diagnosed with a PSA of 3,281, a Gleason of 4+5, multiple enlarged pelvic and abdominal lymph nodes suggestive of metastatic prostate cancer. Paul said he underwent a TRUS guided biopsy April 03, 2008 at which time he was noted to have a 40cc gland. Biopsy confirmed metastatic prostate cancer.
April 29, 2008 Endorectal MRI identified the known disease in the pelvic region as well as T2 signal suggesting extensive intraprostatic involvement and SV extension. His oncologist reported that, “Many would consider this incurable.” He told Paul to go home and get his affairs in order.
June 5, 2008; Started APeX
Aug. 24, 2008; Paul S. in for CT today in our office. Significant reduction in size of his nodes.
Oct. 29, 2008; PSA measured at 0.25, essentially resolved. No abnormal mass is seen.
Sept. 22, 2019, Paul S. continues to have regular check-ups and shows no signs of his previous prostate cancer.
Connie C., Portland, OR. - Stage 4 Breast Cancer
Connie’s history is fascinating. Connie was aware of Jim M's progress with his metastasized lung cancer and soon after he resolved, she learned the devastating news that her breast cancer, in remission for ten years, had returned with a vengeance. Her first diagnosis was grim; cancer had spread aggressively and was in her bones. Her neck bones became so fragile they would break if she turned her head too quickly.
“A malignant right breast mass with 14 of 41 lymph nodes positive for metastatic ductal carcinoma and extensive bone metastases. She is acutely and chronically ill and was told that they could not treat her cancer.
Started APeX in May 2008.
June 26, 2008; “Laboratory studies show a markedly improved white count and hemoglobin and platelet counts that are stable.”
July 10, 2008; “Appetite has improved. She is less depressed, tapering off her pain medication. She is well nourished. Her white count is satisfactory, but there is a slow upward creep in her CA-15-3 to 123.”
August 07, 2008; “She is no longer having problems with depression, chills, bleeding, bruising, or other toxic symptoms; minor signs or symptoms of disease.”
September 11, 2008; “Laboratory studies reveal a white count of 3000, a slight reduction of CA-15-3. She has responded quite nicely to all of this “Standard” therapy.”
October 9, 2008; “The CA-15-3 is holding steady, right around the 100 level. Her pain control is excellent, and she is tapering off her pain medication.”
November 6, 2008; “For the present, we are going to not plan imaging studies, as with a dropping CA-15-3 and improving pain complex and her MRI studies mid-August, the disease appears to be responding quite nicely to her clinical approaches.
November 19, 2008; “Tumor marker CA-15-3 is 73, a slow but steady drop.”
December 4, 2008; “Tumor marker CA-15-3 continues a drop, more rapidly now, and is at 45. Occasional headaches are her only complaint. She is gradually tapering off the H2 blocker.”
December 31, 2008; “Her treatments have continued as her CA-15-3 Markers have progressively improved at 41, and dropping, which is continued evidence of response to treatment.
Appetite has improved to three meals a day.”
It was a long struggle, but a struggle worthy of attention. After several months, Connie C. was feeling stronger, with more energy. She was still having periodic check-ups, which showed rapid improvement with her cancer. We met with Connie on January 11, 2009, to receive her fully redacted medical records. She drove herself to the meeting. She appeared robust and full of energy.
Nicholas U., Washington, D.C. - Stage 4 Inoperable Brain Cancer
Nicholas is a delightful four-year-old boy who was diagnosed at Johns Hopkins Pediatric Oncology with upper spine and brain cancers when he was two years old. His battle has been significant -and noteworthy. According to his mother, Nicholas referred to APeX as his Holy Water.
Nicholas' mother, LeNadra, was referred to APeX by Diane, mother of 16-year-old Adonica B., highlighted below. The prognosis for Nicholas was bleak with a 2% chance of survival and no hope that he would ever lead a healthy life.
September 12, 2009; A mass is evident in the pineal region also occupies the posterior third ventricle, causing a mild amount mass-effect on the tectal plate. Lesion measures approximately 14 X 20 mm in diameter. Slightly increased signal is seen on images. Extensive subarachnoid tumor dissemination within the cisterns of the posterior fossa. Tumor nodules are evident within the foramen of the 9-10-11th cranial nerves.
September 28, 2009; Nicholas began APeX.
December 11, 2009; Findings: The previously noted pineal mass has decreased in size in the interval from previously 20mm depth and 16 mm width X 13 mm height to currently 6x6x7 mm. There remains prominent leptomeningeal enhancement of the cerebral hemispheres, but overall reduced enhancement surrounding the cerebellum, midbrain, and medulla.
July 23, 2009 - Nicholas continues to improve dramatically.
September 15, 2010 - Nicholas has been pronounced fully resolved by pediatric oncologists at Johns Hopkins.
Adonica B., Boynton Beach, FL; Stage 4 Inoperable Brain Cancer
Adonica is a vibrant young woman with a lot of determination and strength. Her story is one of struggle and victory of a teenage girl who won what was considered by the pediatric oncologists, also at Johns Hopkins, to be a hopeless battle with a slim chance of survival, but she refused to give in or give up. As a young teen, she was diagnosed with a mass in her brain stem and spine. Her prognosis was grave at best with a less than 2 percent chance of surviving.
Adonica refused to have chemo or radiation treatments, telling her mother that she was not going to let doctors turn her into a freak. However, at age 16, Adonica was pressured into having brain surgery. She had been on APeX for only a month by the time of the operation, which did not remove all of cancer. Her mother, Diane, was told to bring Adonica back after the surgery had healed so they could do a scan of her brain to determine where to target the radiation. If she did survive the treatment, they told her mother grimly, Adonica would be invalid.
On the day of the scan, Diane called me from the hospital. She was with Adonica in the MRI room, surrounded by doctors. “It’s gone! All the cancer is gone!” she said. “They are looking at the pictures from the scan and they can’t see any cancer. It’s gone!”
The pediatric oncologists at Johns Hopkins were confused and had a hard time believing the images; there was no cancer anywhere to target with radiation. As she continued to progress to a fully resolved state Adonica’s doctors, while not endorsing APeX, told Adonica to keep doing what you are doing - meaning, of course, taking APeX.
December 7, 2010 - Adonica’s mother reports that Adonica’s pediatric oncologist at John’s Hopkins told her that Adonica is now over the age to be treated in the pediatric oncology program. But, that doesn’t matter, he said, Adonica no longer needs an oncologist. Contrary to their grim prognosis, Adonica was resolved entirely and went on to become a champion soccer player who graduated high school as a National Merit Scholar with one of the highest testing scores in the Florida tri-state area.
Adonica received a scholarship from Duke University and, in 2011, graduated with honors. Her last thank you note to APeX Institute added that physically she was back to normal, and she had been accepted into law school. Adonica went on the graduate law school at Duke, also with highest honors, and is now working with a prestigious Washington D. C. law firm.
Barbara B., Quebec, Canada, Stage 4 Colon Cancer
December 13, 2007; “Her report at the Royal Victoria Hospital in Montreal, Canada November 2007 read, “Findings are compatible with rectal CA with extensive hepatic necrotic metastases, retroperitoneal lymph-dermopathy and focal pelvic lymphadenopathy. Innumerable large hypovascular liver metastasis, a 14cm colon tumor and at least 4 ovarian cysts.”
March 17, 2008; “Concerning the previously described lung nodules in the pulmonary embolus study of the largest is stable in size.”
January 15, 2008; “Tumor Marker CEA Value is 3698.0”
Jul 17, 2008, “Tumor Marker CEA Value 109.6”
Jul 29, 2008, “Tumor Marker CEA Value 65.7”
Aug 19, 2008, “Tumor Marker CEA Value 28.3”
Oct 14, 2008, “Tumor Marker CEA Value 7.8”
Nov 25, 2008, “Tumor Marker CEA Value 4.5”
Nov 27, 2008; “CT scan of stomach and pelvis; there has been quite a dramatic decrease in the size of the metastatic liver lesions. No new lesions are identified. All the other lesions are also smaller in size. I see no evidence of retroperitoneal or mesenteric lymphadenopathy. The bones of the thorax and lumbar spine are free of osteoblastic/osteolytic disease.”
Barbara’s story includes a not uncommon misdiagnosis by her Canadian socialized medicine doctors who interpreted her inexplicable improvement as a dire condition. After being informed of her improvement, a member of the Canadian surgical team actually told Barbara, “We don’t understand what is happening, so we feel it is best to operate.”
They told her she could live five years if she had drastic liver surgery, but only two years without it, and the operation had a slim chance of success. Barbara was advised to seek additional medical counsel. On January 20, 2009, Barbara traveled to Pennsylvania and then to Florida to find opinions from two separate doctors. They both agreed without hesitation that, since she was improving so dramatically, such an operation was unnecessary. Barbara did not have the surgery.
She continued on APeX.
April 2009; Barbara’s 12 liver lesions had calcified and were gradually disappearing. Her colon mass had disappeared completely. When Barbara began APeX, she was in hospice. When we first talked, she shared her dream of once going on holiday in Barbados. She feared that her cancer would keep her from that dream. In 2009, a jubilant Barbara and husband Andre called me from Barbados–the first of three such calls.
Unfortunately, in 2011 Barbara’s husband called me with the sad news that Barbara had lost her battle, not with her cancer, but with Canadian doctors who would not believe her progress even though their tests proved conclusively that she was resolved. For whatever reason, Andre told me, her doctor decided to put Barbara on powerful chemo. Three weeks later, Barbara died of a massive liver hemorrhage.